Taavola H - Search Results

1

Montelukast and Nightmares: Further Characterisation Using Data from VigiBase.

Watson S, Kaminsky E, Taavola H, Attalla M, Yue QY. Watson S, et al. Among authors: taavola h. Drug Saf. 2022 Jun;45(6):675-684. doi: 10.1007/s40264-022-01183-2. Epub 2022 Jun 1. Drug Saf. 2022. PMID: 35650509 Free PMC article.

2

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.

Watson S, Chandler RE, Taavola H, Härmark L, Grundmark B, Zekarias A, Star K, van Hunsel F. Watson S, et al. Among authors: taavola h. Drug Saf. 2018 Feb;41(2):203-212. doi: 10.1007/s40264-017-0594-2. Drug Saf. 2018. PMID: 28933055 Free PMC article.

3

Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge.

Rudolph A, Mitchell J, Barrett J, Sköld H, Taavola H, Erlanson N, Melgarejo-González C, Yue QY. Rudolph A, et al. Among authors: taavola h. Ther Adv Drug Saf. 2022 Aug 25;13:20420986221118972. doi: 10.1177/20420986221118972. eCollection 2022. Ther Adv Drug Saf. 2022. PMID: 36052399 Free PMC article. Review.

4

Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports.

Wakao R, Taavola H, Sandberg L, Iwasa E, Soejima S, Chandler R, Norén GN. Wakao R, et al. Among authors: taavola h. Drug Saf. 2019 Dec;42(12):1487-1498. doi: 10.1007/s40264-019-00861-y. Drug Saf. 2019. PMID: 31559542 Free PMC article.

5

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase.

Sandberg L, Taavola H, Aoki Y, Chandler R, Norén GN. Sandberg L, et al. Among authors: taavola h. Drug Saf. 2020 Oct;43(10):999-1009. doi: 10.1007/s40264-020-00957-w. Drug Saf. 2020. PMID: 32564242 Free PMC article.

6

Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study.

Oosterhuis I, Taavola H, Tregunno PM, Mas P, Gama S, Newbould V, Caster O, Härmark L. Oosterhuis I, et al. Among authors: taavola h. Drug Saf. 2018 Oct;41(10):969-978. doi: 10.1007/s40264-018-0679-6. Drug Saf. 2018. PMID: 29761281 Free PMC article.

7

Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting.

Iwasa E, Fujiyoshi Y, Kubota Y, Kimura R, Chandler RE, Taavola H, Norén GN, Wakao R. Iwasa E, et al. Among authors: taavola h. Drug Saf. 2020 Nov;43(11):1121-1131. doi: 10.1007/s40264-020-00968-7. Drug Saf. 2020. PMID: 32617874 Free PMC article.

8

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports.

Ekhart C, van Hunsel F, van Puijenbroek E, Chandler R, Meldau EL, Taavola H, Norén GN. Ekhart C, et al. Among authors: taavola h. Drug Saf. 2022 Feb;45(2):145-153. doi: 10.1007/s40264-021-01139-y. Epub 2022 Jan 12. Drug Saf. 2022. PMID: 35020178 Free PMC article.

9

Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database.

Rolfes L, van Hunsel F, Caster O, Taavola H, Taxis K, van Puijenbroek E. Rolfes L, et al. Among authors: taavola h. Br J Clin Pharmacol. 2018 Jul;84(7):1514-1524. doi: 10.1111/bcp.13576. Epub 2018 Apr 19. Br J Clin Pharmacol. 2018. PMID: 29522255 Free PMC article.

10

Measurement of the

ν_{μ}

energy spectrum with IceCube-79: IceCube Collaboration.

Aartsen MG, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Al Samarai I, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Archinger M, Argüelles C, Auffenberg J, Axani S, Bagherpour H, Bai X, Barwick SW, Baum V, Bay R, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berley D, Bernardini E, Besson DZ, Binder G, Bindig D, Blaufuss E, Blot S, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Bradascio F, Braun J, Brayeur L, Bretz HP, Bron S, Burgman A, Carver T, Casier M, Cheung E, Chirkin D, Christov A, Clark K, Classen L, Coenders S, Collin GH, Conrad JM, Cowen DF, Cross R, Day M, de André JPAM, De Clercq C, Del Pino Rosendo E, Dembinski H, De Ridder S, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Díaz-Vélez JC, di Lorenzo V, Dujmovic H, Dumm JP, Dunkman M, Eberhardt B, Ehrhardt T, Eichmann B, Eller P, Euler S, Evenson PA, Fahey S, Fazely AR, Feintzeig J, Felde J, Filimonov K, Finley C, Flis S, Fösig CC, Franckowiak A, Friedman E, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Ghorbani K, Giang W, Gladstone L, Glauch T, Glüsenkamp T, Goldschmidt A, Gonzalez JG, Grant D, Griffith Z, Haack C, Hallgren A, Halzen F, Hansen E, Hansmann T, Hanson K, Hebecker D,… See abstract for full author list ➔ Aartsen MG, et al. Among authors: taavola h. Eur Phys J C Part Fields. 2017;77(10):692. doi: 10.1140/epjc/s10052-017-5261-3. Epub 2017 Oct 20. Eur Phys J C Part Fields. 2017. PMID: 31997925 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters